Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.015
-0.155 (-13.25%)
At close: Aug 14, 2026, 4:00 PM EDT
1.010
-0.005 (-0.49%)
After-hours: Aug 14, 2026, 7:51 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $16.22 million as of August 14, 2026. Its market cap has decreased by -60.89% in one year.
Market Cap
16.22M
Enterprise Value
23.00M
1-Year Change
-60.89%
Ranking
Category
Stock Price
$1.02
ChartMarket Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $16.22M, a decrease of -81.70%. That is a compound annual growth rate of -28.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 16.22M | 14.70% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Citius Pharmaceuticals | 20.14M |
| Celularity | 20.13M |
| Polyrizon | 20.12M |
| Cellectar Biosciences | 19.82M |
| NewcelX | 19.38M |
| Skye Bioscience | 19.01M |
| Werewolf Therapeutics | 18.76M |
| Marker Therapeutics | 18.51M |